---
document_datetime: 2025-11-23 14:30:03
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/fexeric.html
document_name: fexeric.html
version: success
processing_time: 0.108017
conversion_datetime: 2025-12-28 03:25:37.206132
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Fexeric

[RSS](/en/individual-human-medicine.xml/66755)

##### Lapsed

This medicine's authorisation has lapsed

ferric citrate coordination complex

Medicine

Human

Lapsed

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Fexeric](#news-on)
- [More information on Fexeric](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 13 January 2020, the marketing authorisation of Fexeric (ferric citrate coordination complex) ceases to be valid in the European Union (EU). The cessation of validity is due to the fact that the marketing authorisation holder, Keryx Biopharma UK Ltd., had not marketed Fexeric in the EU since its initial marketing authorisation.

In accordance with the provisions of the sunset clause, the marketing authorisation of the medicinal product lapsed as the product had not been placed on the market in any of the EU Member States within three years of its initial authorisation and during the two extensions which were granted by the European Commission at the end of the three-year period.

Akebia Europe Limited confirmed that the product had not been marketed due to delays in identifying a commercial partner for the EU market. Fexeric was granted marketing authorisation in the EU on 23 September 2015 for the treatment of hyperphosphataemia in patients with chronic kidney disease. The marketing authorisation was initially valid for a 5-year period.

The European Public Assessment Report (EPAR) for Fexeric will be updated to indicate that the marketing authorisation is no longer valid.

Fexeric : EPAR - Summary for the public

Reference Number: EMA/510659/2015

English (EN) (252.54 KB - PDF)

**First published:** 02/10/2015

**Last updated:** 02/10/2015

[View](/en/documents/overview/fexeric-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-471)

български (BG) (314.37 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/bg/documents/overview/fexeric-epar-summary-public_bg.pdf)

español (ES) (250.12 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/es/documents/overview/fexeric-epar-summary-public_es.pdf)

čeština (CS) (302.38 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/cs/documents/overview/fexeric-epar-summary-public_cs.pdf)

dansk (DA) (248.78 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/da/documents/overview/fexeric-epar-summary-public_da.pdf)

Deutsch (DE) (252.04 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/de/documents/overview/fexeric-epar-summary-public_de.pdf)

eesti keel (ET) (245.44 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/et/documents/overview/fexeric-epar-summary-public_et.pdf)

ελληνικά (EL) (319.23 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/el/documents/overview/fexeric-epar-summary-public_el.pdf)

français (FR) (251.51 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/fr/documents/overview/fexeric-epar-summary-public_fr.pdf)

hrvatski (HR) (272.5 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/hr/documents/overview/fexeric-epar-summary-public_hr.pdf)

italiano (IT) (249.08 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/it/documents/overview/fexeric-epar-summary-public_it.pdf)

latviešu valoda (LV) (286.47 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/lv/documents/overview/fexeric-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (276.98 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/lt/documents/overview/fexeric-epar-summary-public_lt.pdf)

magyar (HU) (293.07 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/hu/documents/overview/fexeric-epar-summary-public_hu.pdf)

Malti (MT) (301.08 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/mt/documents/overview/fexeric-epar-summary-public_mt.pdf)

Nederlands (NL) (249.38 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/nl/documents/overview/fexeric-epar-summary-public_nl.pdf)

polski (PL) (298.3 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/pl/documents/overview/fexeric-epar-summary-public_pl.pdf)

português (PT) (249.69 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/pt/documents/overview/fexeric-epar-summary-public_pt.pdf)

română (RO) (273.96 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/ro/documents/overview/fexeric-epar-summary-public_ro.pdf)

slovenčina (SK) (300.34 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/sk/documents/overview/fexeric-epar-summary-public_sk.pdf)

slovenščina (SL) (290.33 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/sl/documents/overview/fexeric-epar-summary-public_sl.pdf)

Suomi (FI) (248.57 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/fi/documents/overview/fexeric-epar-summary-public_fi.pdf)

svenska (SV) (246.33 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/sv/documents/overview/fexeric-epar-summary-public_sv.pdf)

Fexeric : EPAR - Risk-management-plan summary

Reference Number: EMA/576868/2015

English (EN) (259.25 KB - PDF)

**First published:** 02/10/2015

**Last updated:** 02/10/2015

[View](/en/documents/rmp-summary/fexeric-epar-risk-management-plan-summary_en.pdf)

## Product information

Fexeric : EPAR - Product Information

English (EN) (463.01 KB - PDF)

**First published:** 02/10/2015

**Last updated:** 09/10/2019

[View](/en/documents/product-information/fexeric-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-565)

български (BG) (937.09 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/bg/documents/product-information/fexeric-epar-product-information_bg.pdf)

español (ES) (462.93 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/es/documents/product-information/fexeric-epar-product-information_es.pdf)

čeština (CS) (787.3 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/cs/documents/product-information/fexeric-epar-product-information_cs.pdf)

dansk (DA) (465.89 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/da/documents/product-information/fexeric-epar-product-information_da.pdf)

Deutsch (DE) (490.13 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/de/documents/product-information/fexeric-epar-product-information_de.pdf)

eesti keel (ET) (468.75 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/et/documents/product-information/fexeric-epar-product-information_et.pdf)

ελληνικά (EL) (972.13 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/el/documents/product-information/fexeric-epar-product-information_el.pdf)

français (FR) (483.29 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/fr/documents/product-information/fexeric-epar-product-information_fr.pdf)

hrvatski (HR) (572.88 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/hr/documents/product-information/fexeric-epar-product-information_hr.pdf)

íslenska (IS) (471.06 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/is/documents/product-information/fexeric-epar-product-information_is.pdf)

italiano (IT) (476.59 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/it/documents/product-information/fexeric-epar-product-information_it.pdf)

latviešu valoda (LV) (785.64 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/lv/documents/product-information/fexeric-epar-product-information_lv.pdf)

lietuvių kalba (LT) (584.34 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/lt/documents/product-information/fexeric-epar-product-information_lt.pdf)

magyar (HU) (776.26 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/hu/documents/product-information/fexeric-epar-product-information_hu.pdf)

Malti (MT) (802.5 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/mt/documents/product-information/fexeric-epar-product-information_mt.pdf)

Nederlands (NL) (485.05 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/nl/documents/product-information/fexeric-epar-product-information_nl.pdf)

norsk (NO) (480.48 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/no/documents/product-information/fexeric-epar-product-information_no.pdf)

polski (PL) (793.89 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/pl/documents/product-information/fexeric-epar-product-information_pl.pdf)

português (PT) (461.27 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/pt/documents/product-information/fexeric-epar-product-information_pt.pdf)

română (RO) (588.89 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/ro/documents/product-information/fexeric-epar-product-information_ro.pdf)

slovenčina (SK) (770.04 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/sk/documents/product-information/fexeric-epar-product-information_sk.pdf)

slovenščina (SL) (728.68 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/sl/documents/product-information/fexeric-epar-product-information_sl.pdf)

Suomi (FI) (459.1 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/fi/documents/product-information/fexeric-epar-product-information_fi.pdf)

svenska (SV) (466.98 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

09/10/2019

[View](/sv/documents/product-information/fexeric-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** T/0015 09/09/2019

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Fexeric : EPAR - All Authorised presentations

English (EN) (178.18 KB - PDF)

**First published:** 02/10/2015

**Last updated:** 02/10/2015

[View](/en/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-437)

български (BG) (210.72 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/bg/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_bg.pdf)

español (ES) (180.58 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/es/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_es.pdf)

čeština (CS) (201.02 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/cs/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (180.26 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/da/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (180.23 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/de/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (180.39 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/et/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (211.9 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/el/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_el.pdf)

français (FR) (180.33 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/fr/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (193.25 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/hr/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (181.64 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/is/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_is.pdf)

italiano (IT) (180.4 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/it/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (205.72 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/lv/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (196.89 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/lt/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (200.44 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/hu/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (201.34 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/mt/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (180.21 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/nl/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (181.79 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/no/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_no.pdf)

polski (PL) (195.46 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/pl/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_pl.pdf)

português (PT) (180.35 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/pt/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_pt.pdf)

română (RO) (195.44 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/ro/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (201.5 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/sk/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (193.66 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/sl/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (180.12 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/fi/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (180.33 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

02/10/2015

[View](/sv/documents/all-authorised-presentations/fexeric-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Fexeric Active substance ferric citrate coordination complex International non-proprietary name (INN) or common name ferric citrate coordination complex Therapeutic area (MeSH)

- Hyperphosphatemia
- Renal Dialysis

Anatomical therapeutic chemical (ATC) code V03AE

### Therapeutic indication

Fexeric is indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease (CKD).

## Authorisation details

EMA product number EMEA/H/C/003776 Marketing authorisation holder

Akebia Europe Limited

c/o Matheson

Marketing authorisation issued 23/09/2015 Lapse of marketing authorisation 13/01/2020 Revision 2

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Fexeric : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (320.19 KB - PDF)

**First published:** 17/11/2016

**Last updated:** 09/10/2019

[View](/en/documents/procedural-steps-after/fexeric-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Fexeric : EPAR - Public assessment report

Adopted

Reference Number: EMA/CHMP/535898/2015

English (EN) (3.31 MB - PDF)

**First published:** 02/10/2015

**Last updated:** 02/10/2015

[View](/en/documents/assessment-report/fexeric-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Fexeric

Adopted

Reference Number: EMA/CHMP/453873/2015

English (EN) (292.85 KB - PDF)

**First published:** 24/07/2015

**Last updated:** 24/07/2015

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-fexeric_en.pdf)

#### News on Fexeric

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2015](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-july-2015) 24/07/2015

#### More information on Fexeric

- [EMEA-001213-PIP02-12-M02 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-001213-pip02-12-m02)

**This page was last updated on** 04/02/2020

## Share this page

[Back to top](#main-content)